2Inoue J I, Gohda J, Akiyama T, et al. NF-kappa B activation in development and progression of cancer[J]. Cancer Sci, 2007, 98(3): 268.
3Karin M. Nuclear factor-kappaB in cancer developmentnd progression[J]. Nature, 2006, 441(792): 431.
4Baldwin A S. Series introduction: the transcription factor NF- kappaB and human disease[J]. J Clin Invest, 2001, 107(1): 3.
5O'dea E, Hoffmann A. The regulatory logic of the NF-kappaB signaling system[J]. Cold Spring Harb Perspeet Biol, 2010, 2(1): a000216.
6Oeckinghaus A, Ghosh S. The NF-kappa B family of transcription factors and its regulation [J]. Cold Spring Harb Perspect Biol, 2009, 1(4): a000034.
7Karin M, Greten F R. NF-kappaB: linking inflammation and immunity to cancer development and progression[J]. Nat Rev Immunol, 2005, 5(10): 749.
8Luo J L, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing Life and death-a new approach to cancer therapy[J]. J Clin Invest, 2005, 115(10): 2625.
9Kaisho T, Takeda K, Tsujimura T, et al. IkappaB kinase alpha is essential for mature B cell development and function[J]. J Exp Med, 2001, 193(4): 417.
10Pahl H L. Activators and target genes of Rel/NF-kappaB transcription factors[J]. Oncogene, 1999, 18(49): 6853.
4Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin,2005,55(2) :74-108.
5Choi I K, Shin H J, Lee H S, et al. Streptochlorin, a marine natural product, inhibits NF-kappaB activation and suppresses angiogenesis in vitro[J]. J Microbiol Biotechnol, 2007, 17 (8) 1338 -1343.
6Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF) C and VEGF D in tumors and its relationship to lymphatic metastasis in immunocompetent rats[J].Cancer Res, 2003, 63 (3):713-722.
7Kuntzen C, Zazzeroni F, Pham C G, et al. A method for isolating prosurvival targets of NF kappaB/Rel transcription factors [J].Methods Mol Biol, 2007, 399:99- 124.
8Lee C H, Jeon Y T, KimS H, et al. NF kappaBas a potential molecular target for cancer therapy[J]. Biofaetors, 2007,29 (1):19- 35.
9Wu J T,Kral J G. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy[J]. J Surg Res,2005, 123(1) : 158-169.
10Kim J G, Chae Y S, Sohn S K, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer[J]. Clin Cancer Res, 2008, 14 (1): 62-66.
